Raisin is a Berlin-based fintech that runs a pan-European and US savings and investment marketplace, letting retail customers shop competitive interest rates across hundreds of partner banks from a single account, while giving banks an on-demand channel to gather deposits. Beyond its consumer marketplace, Raisin licenses white-label 'savings-as-a-service' technology to financial institutions and offers ETF, pension and investment products. The company surpassed one million customers, turned profitable in 2022 after a decade of operation, and intermediates tens of billions of euros in deposits across more than 30 markets.
Unlimited is a New York fintech that uses proprietary machine-learning technology to replicate the returns of hedge fund strategies inside low-cost, liquid ETFs. Founded in 2022 by former Bridgewater executive Bob Elliott, it aims to give everyday investors access to 2-and-20 style alternative strategies without the 2-and-20 fees, lockups, or opacity.
Bob Elliott is the co-founder, CEO and CIO of Unlimited Funds, a New York firm that uses Bayesian machine learning to replicate the returns of hedge funds, venture capital and private equity inside low-cost ETFs. A Harvard-trained botanist turned macro investor, he spent roughly 15 years at Bridgewater Associates, where he sat on the Investment Committee, helped run the flagship Pure Alpha fund, and built and led Ray Dalio's personal research team for nearly a decade. Today he is one of the most-followed independent macro voices on financial Twitter and the manager behind the HFND and HFGM ETFs.
Meb Faber is the co-founder and Chief Investment Officer of Cambria Investment Management, overseeing roughly $20 billion in assets across a suite of quantitative ETFs and private funds. A prolific author of six investing books (all free to download), host of the top-rated Meb Faber Show podcast with 615+ episodes, and curator of The Idea Farm newsletter reaching 100,000+ subscribers, Faber has made a career out of democratizing evidence-based investing - blending rigorous quantitative research with a rare willingness to share it all for free.